Adaptive Biotechnologies: A Platform Play For Immune Driven Medicine (NASDAQ:ADPT) | Seeking Alpha
Career Listings - Adaptive Biotech
Adaptive Biotechnologies Corp. | LinkedIn
Adaptive Biotechnologies - Adaptive Biotechnologies to Enter into Worldwide Collaboration and License Agreement with Genentech to Develop Personalized Cellular Therapies for the Treatment of Cancer
Shares of Adaptive Biotechnologies double in hot IPO | The Seattle Times
Adaptive Biotechnologies Corp. | LinkedIn
Short Interest in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Decreases By 6.6% - MarketBeat